Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bu Shen Tiao Xue Therapy Duration for IVF in DOR Patients
NCT05577455Phase 3Unknown
- Sponsor
- Peking University Third Hospital
- Start
- Nov 2022
- Primary completion
- Dec 2024
01
Overview
Phase 3, randomised, open-label trial in Diminished Ovarian Reserve (DOR) and infertility (2 arms), sponsored by Peking University Third Hospital. Primary endpoint: Number of oocytes retrieved up to 15 weeks. Status: unknown.
02
Conditions
Diminished Ovarian Reserve (DOR)infertility
Beyond the preview
Go deeper on NCT05577455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05577455.